Nordian has sold IGS to Smile Invest

Client: Nordian Capital Partners

Client Headquarters: Netherlands

Target: IGS International

Target Headquarters: Netherlands

Acquirer: Smile Invest

Acquirer Headquarters: Belgium

Target Description: IGS makes high-precision, multi-cavity injection molds for contact lenses and medical devices such as inhalers and insulin pens.

Nordian IGS Smile 2021
  • 2021
    Close Year
  • Industrials
  • Private Equity
    Client Type
  • Financial | Cross-border
    Transaction Type
  • Belgium | Netherlands

Meet our Senior Team